Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 5/20 | 0.41 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.38 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.38 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | S100A4 | P26447 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | GPR3 | P46089 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24272471 | 0.92 | PDK2 (0.44) | PDK2AKR1A1AKR1B1P2RX7CNR1 | |
| SCHEMBL24272494 | 0.85 | PDK2 (0.36) | PDK2AKR1A1AKR1B1 | |
| SCHEMBL24272472 | 0.84 | PDK2 (0.40) | PDK2 | |
| SCHEMBL24272563 | 0.84 | PDK2 (0.33) | PDK2AKR1A1AKR1B1CNR1 | |
| SCHEMBL22780112 | 0.80 | PDK2 (0.45) | PDK2AKR1A1AKR1B1S100A4GPR3 | |
| SCHEMBL29733681 | 0.80 | PDK2 (0.45) | PDK2AKR1A1AKR1B1S100A4GPR3 | |
| SCHEMBL24627068 | 0.80 | MAPK14 (0.39) | PDK2P2RX7 | |
| SCHEMBL23628262 | 0.79 | PDK2 (0.40) | PDK2P2RX7 | |
| SCHEMBL23614642 | 0.78 | PDK2 (0.33) | PDK2 | |
| SCHEMBL23331967 | 0.78 | PDK2 (0.41) | PDK2P2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220223800-A1 | ORGANIC COMPOUND, ELECTRONIC COMPONENT, AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2022-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220223800-A1 | ORGANIC COMPOUND, ELECTRONIC COMPONENT, AND ELECTRONIC DEVICE | OCIAD2, EMC2, OCIAD1 | PDK2 1517/4885AKR1A1 1468/4885AKR1B1 1601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.